<DOC>
	<DOC>NCT01349387</DOC>
	<brief_summary>Main objective : Show that treatment with metformin in patients with type 2 diabetes has an effect on alternative splicing of the insulin receptor. Secondary objective : demonstrate that the effect on the ratio A/isoform B isoform with discontinuation of treatment with metformin can be réversé by the resumption of metformin treatment.</brief_summary>
	<brief_title>Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 Diabetic patients usually treated with metformin (≥ 1400 mg/day), associated or not to other oral antidiabetic treatment or. injection treatment Patients major. Patients with a social security number Patients having signed a consent to participate in the study Intolerance metformin Patients with type 1. Patients on pioglitazone or rosiglitazone Renal failure by an anomaly of the creatinine clearance (&lt; 60 mL/min). Patients pregnant or likely to be.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>